OBIO · NASDAQ
Orchestra BioMed Holdings (OBIO) Stock Price & Fundamentals
Orchestra BioMed Holdings (OBIO) closed at $1,367.59 on Oct 9, 2026, up 0.86% from the previous close of $1,355.92.
Share price, past year
1Y +43.85%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,367.59 |
| Sep 30, 2026 | $1,315.45 |
| Aug 31, 2026 | $1,276.90 |
| Jul 31, 2026 | $1,231.97 |
| Jun 30, 2026 | $1,171.47 |
| May 29, 2026 | $1,121.48 |
| Apr 30, 2026 | $1,163.14 |
| Mar 31, 2026 | $1,189.75 |
| Feb 27, 2026 | $1,098.77 |
| Jan 30, 2026 | $1,095.74 |
| Dec 31, 2025 | $1,057.25 |
| Nov 28, 2025 | $1,011.56 |
| Oct 31, 2025 | $982.62 |
Key statistics
- Market cap
- $82.20B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.83
- Revenue (TTM)
- $31.98M
- Net income (TTM)
- −$59.03M
- Shares outstanding
- 60.1M
- Dividend yield
- —
- 52-week range
- $942.00 – $1,367.59
Orchestra BioMed Holdings's market cap is $82.20B, based on a share price of $1,367.59 and 60.1M shares outstanding as of Jun 30, 2026.
Financials
Orchestra BioMed Holdings reported revenue of $33.48M for fiscal 2025, up 1,169.22% from fiscal 2024.
Orchestra BioMed Holdings reported a net loss of $52.70M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $33.48M | +1,169.2% | −$52.70M | −157.4% | −$1.11 | −$49.45M |
| FY2024ended Dec 31, 2024 | $2.64M | −4.4% | −$61.02M | −2,313.3% | −$1.66 | −$50.85M |
| FY2023ended Dec 31, 2023 | $2.76M | −21.9% | −$49.12M | −1,779.7% | −$1.48 | −$46.21M |
| FY2022ended Dec 31, 2022 | $3.53M | — | −$33.61M | −951.3% | −$2.24 | −$29.88M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $88.00K | −$23.76M | −$0.38 |
| Q1 FY2026ended Mar 31, 2026 | $110.00K | −$20.69M | −$0.33 |
| Q4 FY2025ended Dec 31, 2025 | $30.92M | $6.25M | $0.28 |
| Q3 FY2025ended Sep 30, 2025 | $861.00K | −$20.83M | −$0.40 |
| Q2 FY2025ended Jun 30, 2025 | $836.00K | −$19.36M | −$0.50 |
| Q1 FY2025ended Mar 31, 2025 | $868.00K | −$18.76M | −$0.49 |
| Q4 FY2024ended Dec 31, 2024 | $253.00K | −$16.16M | −$0.42 |
| Q3 FY2024ended Sep 30, 2024 | $987.00K | −$15.43M | −$0.41 |
Company profile
- Name
- Orchestra BioMed Holdings, Inc.
- Ticker
- OBIO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 150 Union Square Drive, New Hope, PA 18938
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001814114
Recent SEC filings
- Oct 1, 2026
- Sep 8, 2026
- Aug 10, 2026
- Jun 23, 2026
- May 12, 2026
- Mar 12, 2026
- Feb 13, 2026
- Jan 12, 2026
Frequently asked questions
What is Orchestra BioMed Holdings's stock price?
Orchestra BioMed Holdings (OBIO) closed at $1,367.59 on Oct 9, 2026, up 0.86% from the previous close of $1,355.92.
What is Orchestra BioMed Holdings's market cap?
Orchestra BioMed Holdings's market cap is $82.20B, based on a share price of $1,367.59 and 60.1M shares outstanding as of Jun 30, 2026.
How much revenue does Orchestra BioMed Holdings make?
Orchestra BioMed Holdings reported revenue of $33.48M for fiscal 2025, up 1,169.22% from fiscal 2024.
Does Orchestra BioMed Holdings pay a dividend?
Orchestra BioMed Holdings's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Orchestra BioMed Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures